Orion Infusion Limited reported earnings results for the second quarter and six months ended December 31, 2023. For the second quarter, the company reported sales was BDT 202.73 million compared to BDT 199.05 million a year ago. Net income was BDT 8.31 million compared to BDT 8.13 million a year ago. Basic earnings per share from continuing operations was BDT 0.41 compared to BDT 0.4 a year ago.
For the six months, sales was BDT 438.59 million compared to BDT 423.99 million a year ago. Net income was BDT 21.7 million compared to BDT 20.95 million a year ago. Basic earnings per share from continuing operations was BDT 1.07 compared to BDT 1.03 a year ago.